Register Login
Register to leave comments
  • News bot May 8, 2026, 1:11 p.m.

    📋 BIOAGE LABS, INC. (BIOA) - Financial Results

    Filing Date: 2026-05-08

    Accepted: 2026-05-08 09:10:20

    Event Type: Financial Results

    Event Details:

    BIOAGE LABS, INC. (BIOA) Reports the reporting period Financial Results BIOAGE LABS, INC. (BIOA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 6191
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 241777
      • In April 2026, BioAge reported positive topline data from the Phase 1 trial of BGE
      • penetrant NLRP3 inhibitor, including a newly announced 60 mg once
      • daily cohort in participants with obesity and elevated inflammation.
        • anticipated by year end.BGE-102 indication expansion into ophthalmology•In January 2026
        • targeting novel metabolic aging targets. First Quarter 2026
        • anticipated in mid-2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 25.38K 16.45K $8.93K +54.29%
    Other Income Expense Interest Expense 39.00 255.00 $-216.00 -84.71%
    Other Income Expense Total Other Income Expense 3.12K 3.52K $-396.00 -11.26%
    Other Income Expense Net Loss 22.25K 12.93K $9.32K +72.13%
    Comprehensive Loss Net Loss 22.25K 12.93K $9.32K +72.13%
    Current Assets Prepaid Expenses Other Current Assets 7.96K 4.93K $3.03K +61.53%
    Current Assets Property Equipment Net 1.11K 963.00 $152.00 +15.78%
    Current Assets Operating Lease Right Of Use Assets 2.68K 2.79K $-101.00 -3.63%
    Current Assets Other Assets 215.00 216.00 $-1.00 -0.46%
    Current Liabilities Accounts Payable 3.07K 2.67K $392.00 +14.66%
    Current Liabilities Operating Lease Liabilities 2.23K 2.33K $-101.00 -4.33%
    Revenue 2.77K 1.45K $1.32K +91.04%
    Loss from Operations 25.38K 16.45K $8.93K +54.29%
    Interest Expense 39.00 255.00 $-216.00 -84.71%
    Total Other Income/(Expense) 3.12K 3.52K $-396.00 -11.26%
    Net Loss 22.25K 12.93K $9.32K +72.13%
    Prepaid Expenses and Other Current Assets 7.96K 4.93K $3.03K +61.53%
    Property and Equipment, Net 1.11K 963.00 $152.00 +15.78%
    Other Assets 215.00 216.00 $-1.00 -0.46%
    Accounts Payable 3.07K 2.67K $392.00 +14.66%
    Operating Lease Liabilities 646.00 582.00 $64.00 +11.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOAGE LABS, INC.
    • Ticker Symbol: BIOA

Search

News categories